Dis-Chem annual profit down 1.6%, continues to roll out new pharmacies
--:--
GUEST – Rui Morais, Dis-Chem CEO
South African pharmacy group Dis-Chem announced in a Sens on Friday that its headline earnings per share declined by 1.6% for the year ended 29 February 2024.
Headline earnings per share were 114.6 cents for the full year ended 31 March 2024, compared to 116.5 cents per share in the corresponding period in 2023.
Dis-Chem declared a gross final cash dividend of 22.493 cents per share for the year ended 29 February 2024, an increase of 21.9% from the previous comparable period.
From 1 March 2023 to 29 February 2024, Dis-Chem Pharmacies recorded group revenue growth of 11.1%, to R36.3 billion, as trading conditions continued to strengthen in line with the first-half statement.
South African pharmacy group Dis-Chem announced in a Sens on Friday that its headline earnings per share declined by 1.6% for the year ended 29 February 2024.
Headline earnings per share were 114.6 cents for the full year ended 31 March 2024, compared to 116.5 cents per share in the corresponding period in 2023.
Dis-Chem declared a gross final cash dividend of 22.493 cents per share for the year ended 29 February 2024, an increase of 21.9% from the previous comparable period.
From 1 March 2023 to 29 February 2024, Dis-Chem Pharmacies recorded group revenue growth of 11.1%, to R36.3 billion, as trading conditions continued to strengthen in line with the first-half statement.